TILS.L Regulatory News (TILS)

30 Nov 2007 11:30

ReGen Therapeutics PLC30 November 2007 ('ReGen' or the Company')Total Voting Rights For the purposes of the Disclosure and Transparency Rules of the FinancialServices Authority, the Board of ReGen is required to notify the market of thefollowing: As at the date of this announcement, the Company's issued share capital consistsof 10,258,878 ordinary shares with a nominal value of 10 p each, with votingrights ("Ordinary Shares"). The Company does not hold any Ordinary Shares in Treasury. Therefore the total number of Ordinary Shares in the Company with voting rightsis 10,258,878. The above figure of 10,258,878 Ordinary Shares may be used by shareholders inthe Company as the denominator for the calculations by which they willdetermine if they are required to notify their interest in, or a change to theirinterest in, the share capital of the Company under the Financial ServiceAuthority's Disclosure and Transparency Rules. ENDS For further information, please contact: Andrew MarshallGreycoat CommunicationsTel No 020 7960 6007 Percy Lomax - Executive ChairmanReGen Therapeutics PlcTel No 020 7153 4920Direct No 020 8504 2156 Roland CornishBeaumont Cornish LimitedTel No 020 7628 3396 Nick BealerKing & Shaxson Capital LimitedTel No 020 7426 5986 This information is provided by RNS The company news service from the London Stock Exchange